REQUEST A DEMO
Total
USD $0.00
Search more companies

Neuron Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Neuron Pharma Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Neuron Pharma Private Limited is an unlisted company, incorporated on 26/02/1996. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24231GJ1996PTC028913 and registration number is 028913. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Plot No. Pf 15, Opp. P & G Pharma , Sanand Gidc Ii
Ahmedabad; Gujarat; Postal Code: 382110

Contact Details: Purchase the Neuron Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Neuron Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Neuron Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Neuron Pharma Private Limited report to view the information.
Incorporation Date:
February 26, 1996
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Neuron Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
0.41%
Total operating revenue
1.69%
Operating profit (EBIT)
70.7%
EBITDA
168.86%
Net Profit (Loss) for the Period
90.35%
Total assets
20.22%
Total equity
419.93%
Operating Profit Margin (ROS)
14.55%
Net Profit Margin
20.18%
Return on Equity (ROE)
329.05%
Debt to Equity Ratio
-1584.49%
Quick Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?